Expression of a leptospiral leucine-rich repeat protein using a food-grade vector in , as a strategy for vaccine delivery.

In this study, a first food-grade mucosal vaccine against leptospirosis was developed without the use of antibiotic resistance gene. This expression system is based on a food-grade host/vector system of and a new vaccine candidate antigen, a leucine-rich repeat (LRR) protein of . The LRR of interest from serovar Sejroe is encoded by two overlapping genes and these genes were fused together by site-directed mutagenesis. The mutant gene thus obtained could be successfully expressed in this system as was shown by western blot analysis and liquid chromatography-mass spectrometry (LC-MS/MS) analysis. In addition, this analysis showed that the mutant LRR protein fused to a homologous signal peptide of could be exported to the cell surface as a result of the native LPXAG motif of the heterologous LRR protein, which presumably is responsible for anchoring the protein to the cell wall of This new strategy could be an essential tool for further studies of leptospirosis mucosal vaccine delivery.